<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001876077</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Shares, par value $1.00 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>03/31/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001877184</issuerCik>
        <issuerName>Kestra Medical Technologies, Ltd.</issuerName>
        <issuerCusip>G52441105</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">3933 Lake Washington Blvd NE</street1>
          <street2 xmlns="http://www.sec.gov/edgar/common">Suite 200</street2>
          <city xmlns="http://www.sec.gov/edgar/common">Kirkland</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">WA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">98003</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bain Charger Holdings, L.P.</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>24949838</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>27019225</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>27019225</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>52.6</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Kestra Medical Technologies, Ltd.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>3933 Lake Washington BLVD NE, Suite 200, Kirkland, WA 98003</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Schedule 13G is being filed by Bain Charger Holdings, L.P., a Delaware limited partnership (the "Reporting Person"). Bain Capital Investors, LLC, a Delaware limited liability company ("BCI" and, together with the Reporting Person, the "Bain Capital Entities"), is the general partner of the Reporting Person. As a result, BCI may be deemed to share voting and dispositive power with respect to the securities held by Bain Charger. Voting and investment decisions with respect to the securities held by the Reporting Person are made by the partners of BCI.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The principal business address for each of the Bain Capital Entities is 200 Clarendon Street, Boston, MA 02116.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Each of the Bain Capital Entities is organized under the laws of the State of Delaware.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>As of the close of business on March 31, 2025, the Reporting Person directly held 7,109,944 Common Shares, representing approximately 13.8% of the Issuer's outstanding Common Shares, and West Affum Holdings, L.P. ("West Affum") directly held 19,909,281 Common Shares, representing approximately 38.8% of the Issuer's outstanding Common Shares.

The Common Shares held directly by West Affum are held for the benefit of the holders of West Affum common units, including the Reporting Person, until the time such Common Shares are distributed to the holders of West Affum common units in accordance with the partnership agreement of West Affum. The Reporting Person is the sole shareholder of West Affum GP Ltd., which is the general partner of West Affum.

As a result of the foregoing, and the relationships described in Item 2(a) of this Schedule 13G, the Reporting Person may be deemed to have (ii) shared voting power with respect to an aggregate of 24,949,838 Common Shares, representing (x) 7,109,944 Common Shares held directly by the Reporting Person and (y) 17,839,894 Common Shares indirectly held by the Reporting Person through West Affum, and (ii) shared dispositive power with respect to an aggregate of 27,019,225 Common Shares.

The percentage of the outstanding Common Shares held by the Reporting Person is based on 51,348,656 Common Shares outstanding as of April 17, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on April 17, 2025.</amountBeneficiallyOwned>
        <classPercent>See Item 4(a) hereof.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See Item 4(a) hereof.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See Item 4(a) hereof.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Bain Charger Holdings, L.P.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Chris Gordon</signature>
        <title>Chris Gordon, Partner of Bain Capital Investors, LLC</title>
        <date>05/15/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
